912332-92-4

Basic information

• Product Name: 6-broMo-2-Methylbenzo[b]thiophene
• Synonyms: 6-broMo-2-Methylbenzo[b]thiophene
• CAS NO: 912332-92-4
• Molecular Formula: C9H7BrS
• Molecular Weight: 227.12088
• Mol File: 912332-92-4.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-broMo-2-Methylbenzo[b]thiophene(CAS DataBase Reference)
• NIST Chemistry Reference: 6-broMo-2-Methylbenzo[b]thiophene(912332-92-4)
• EPA Substance Registry System: 6-broMo-2-Methylbenzo[b]thiophene(912332-92-4)

Safety Data

• Hazardous Substances Data: 912332-92-4(Hazardous Substances Data)

Upstream product

• 17347-32-9 6-bromobenzothiophene 
• 74-88-4 methyl iodide 
• 374933-76-3 6-Brombenzothiophen-2-methanol 
• 57848-46-1 4-bromo-2-fluorobenzaldehyde 
• 360576-01-8 6-bromo-benzo[b]thiophene-2-carboxylic acid methyl ester 

Downstream Products

• 18781-42-5 methyl 2-methylbenzo[b]thiophene-6-carboxylate 

Relevant articles and documents

AMINOISOXAZOLINE COMPOUNDS AS AGONISTS OF ALPHA7-NICOTINIC ACETYLCHOLINE RECEPTORS

The present invention relates to novel aminoisoxazoline compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of α7-nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.

GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTORS

The present invention relates to novel geminal substituted quinuclidine amide compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of α7- nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.

Synthesis of a ferrocene-functionalized unsymmetrical benzo[b]thienyl- thienylethene photoswitch with a cyclopentene core

A new and potentially general synthetic route toward unsymmetrical benzo[b]thienyl-thienylethene compounds is described, with specific focus on conjugation of a ferrocene to the benzo[b]thiophene subunit. The route proceeds in an overall yield of 17%. Copyright

COMPOUNDS, PREPARATIONS AND USES THEREOF

The present invention provides novel compounds of the Formula (I), pharmaceutical compositions comprising such compounds and methods for using such compounds as agents or drugs for inhibiting perforin activity and for treating a subject at risk of or susc

IMIDAZOPYRIDAZINE COMPOUNDS

The present invention relates to novel substituted imidazo[1,2-b] pyridazine compounds of Formula (I) pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurological diseases.